QuidelOrtho Q2 2024 Adj. EPS $(0.07) Beats $(0.23) Estimate, Sales $637.000M Beat $613.537M Estimate
Portfolio Pulse from Benzinga Newsdesk
QuidelOrtho (NASDAQ:QDEL) reported Q2 2024 adjusted EPS of $(0.07), beating the $(0.23) estimate. Sales were $637 million, surpassing the $613.537 million estimate but down 4.22% from last year.
July 31, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
QuidelOrtho's Q2 2024 results beat EPS and sales estimates, with $(0.07) EPS and $637 million in sales. Despite the positive surprise, sales are down 4.22% year-over-year.
The better-than-expected EPS and sales figures are likely to have a positive short-term impact on QDEL's stock price. However, the year-over-year decline in sales may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100